Invention Grant
- Patent Title: Infusion dosage form of norepinephrine
-
Application No.: US17451292Application Date: 2021-10-18
-
Publication No.: US11865089B2Publication Date: 2024-01-09
- Inventor: Samarth Kumar , Maheshkumar Parasmal Soni , Praveen Kumar Srivastava , Prashant Kane , Subhas Balaram Bhowmick
- Applicant: Sun Pharmaceutical Industries Limited
- Applicant Address: IN Mumbai
- Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
- Current Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
- Current Assignee Address: IN Maharashtra
- Agency: Blank Rome LLP
- Priority: IN 1921032096 2019.08.08
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K9/08 ; A61K47/02 ; A61K47/18 ; A61K9/00

Abstract:
The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.
Public/Granted literature
- US20220054434A1 INFUSION DOSAGE FORM OF NOREPINEPHRINE Public/Granted day:2022-02-24
Information query